5/27/2009 | SS | Market Commentary: Amylin gives up two board seats; AOL spinoff buzz increases; Cougar lacks counter bids
|
1/23/2009 | SS | Mentor investors tender 93.9% of shares in offer by Johnson & Johnson; merger closes
|
1/20/2009 | SS | Johnson & Johnson begins subsequent offer for Mentor shares
|
1/16/2009 | SS | Market Commentary: Risks weigh on Terra takeover; Aladdin deal should clear regulatory reviews; Mentor bid expires
|
1/15/2009 | SS | Johnson & Johnson receives all required clearances in proposed acquisition of Mentor
|
1/15/2009 | SS | Market Commentary: Johnson & Johnson offer for Mentor expires Friday; International Shipholding falls on loss of suitor
|
1/9/2009 | SS | Kornitzer Capital reports stake of 3.81% in Mentor
|
1/6/2009 | SS | Johnson & Johnson extends tender offer for Mentor
|
1/6/2009 | SS | Market Commentary: Endo buyout likely to close; Rohm & Haas stock falls below Dow bid; Johnson & Johnson extends offer
|
1/2/2009 | SS | Mentor investor sells shares, converts notes for 5.4% stake
|
1/2/2009 | SS | Market Commentary: Zell homes in on Starwood Hotels; Dynegy quits joint venture
|
12/31/2008 | SS | Mentor investor Gabelli buys 1,841,500 shares
|
12/24/2008 | SS | Market Commentary: Johnson & Johnson tender offer for Omrix expires Friday; Emageon buyout lacks financing
|
12/22/2008 | SS | Market Commentary: Johnson & Johnson, King Pharma buyouts considered done deals; InfoGroup founder explores sale
|
12/15/2008 | SS | Mentor shareholder HBK buys 1.1 million shares
|
12/12/2008 | SS | Johnson & Johnson begins tender offer for Mentor
|
12/12/2008 | SS | Market Commentary: PNC, NatCity await Fed blessing; tender for Mentor opens; Rodman & Renshaw sticks to takeover target
|
12/2/2008 | CV | Mentor calls 2.75% convertibles
|
12/1/2008 | CV | Market Commentary: Mentor bucks trend, gains on takeover; Citigroup drops with stocks; energy names fall on OPEC move
|
12/1/2008 | SS | Johnson & Johnson to acquire Mentor for $1.07 billion
|
12/1/2008 | SS | Market Commentary: J&J offer sends Mentor up 89.35%; Sprint Nextel, Clearwire close deal; BCE shares set new low
|
10/1/2008 | CV | Mentor secures funds to pay call or put of 2.75% convertibles
|
10/1/2008 | BK | Mentor amends credit facility, extending maturity
|
5/15/2006 | BT | Mentor to study botulinum toxin to treat head, neck spasms
|
4/21/2006 | BT | Mentor receives FDA approval for synthetic mesh product for pelvic organ prolapse
|
4/3/2006 | BT | Mentor seeks marketing approval for gel-based implants
|
3/27/2006 | BT | Mentor to sell urology business to Coloplast for $463 million
|
11/21/2005 | BT | Medicis rebuffs Mentor's $2.2 billion merger offer, says it is committed to deal with Inamed
|
11/21/2005 | BT | Market Commentary: Incyte zooms on R&D pact with Pfizer; Medicis, Mentor, Allergan, Inamed tangle in merger scuffle
|
10/27/2005 | BT | Mentor begins phase 2 study of botulinum toxin type A product for wrinkle treatment
|
6/1/2005 | BK | Mentor obtains new $200 million credit facility
|
12/18/2003 | CV | Market Commentary: New deals higher, but volume slows as market begins to focus on weekend, holidays
|
12/17/2003 | CV | Market Commentary: All new deals soar, but small Fleetwood shines, rises to 112; Kroll adds $150 million overnighter
|
12/17/2003 | CV | Mentor $125 million convertible yields 2.75%, up 30%
|
12/16/2003 | CV | Mentor $125 million convertible talked at 2.75-3.25% yield, up 25-30%
|
12/16/2003 | CV | Market Commentary: Four deals to price after the close Tuesday; Mentor adds $125 million overnighter
|